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Abstract 
We investigated the anti-proliferative effects of an olive oil polyphenolic extract on human colon 
adenocarcinoma cells. Analysis indicated that the extract contained hydroxytyrosol, tyrosol and the various 
secoiridoid derivatives, including oleuropein.  This extract exerted a strong inhibitory effect on cell 
proliferation, which was linked to the induction of a G2/M phase cell cycle block. Following treatment with the 
extract (50 µg/ml) the number of cells in the G2/M phase increased to 51.82 ± 2.69% relative to control cells 
(15.1 ± 2.5 %).  This G2/M block was mediated by the ability of olive oil polyphenols (50 μg/ml) to exert rapid 
inhibition of p38 (38.7 ± 4.7%) and CREB (28.6 ± 5.5%) phosphorylation which led to a downstream 
reduction in COX-2 expression (56.9 ± 9.3 %).  Our data suggest that olive oil polyphenols may exert 
chemopreventative effects in the large intestine by interacting with signalling pathways responsible for 










The regular consumption of olive oil has been suggested to be one of the factors associated with a lower 
incidence of coronary heart disease and certain cancers, in particular colon cancer, in Mediterranean 
countries compared to those in Northern Europe [1].  For example, olive oil consumption has been shown to 
reduce the incidence of aberrant crypt foci in azoxymethane-treated rats [2] and dimethyl-benz(a)antracene-
induced mammary carcinogenesis [3].  Furthermore, olive oil intake has been shown to induce significant 
levels of apoptosis in large intestinal cancer cells [4]. These anti-cancer properties [5] are thought to be 
mediated by phenolic compounds present in olive oil, such as hydroxytyrosol [6], lignans [7] and secoiridoids 
[8].  For example, a polyphenolic fraction extracted from olive oil has been shown to inhibit human 
promyelocytic leukemia cell (HL60) proliferation by inducing apoptosis and differentiation [9].  Although the 
exact mechanism by which olive oil exerts its anticancer action is unknown, the down-regulation of COX-2 
and Bcl-2 expression, which plays a critical role in colorectal carcinogenesis, has been suggested [4].   
 
The biological properties of olive oil polyphenols in vivo will depend on the extent of their absorption and 
metabolism in the gastrointestinal tract.  We have recently shown that although hydroxytyrosol and tyrosol 
are absorbed and metabolised in the small intestine, oleuropein, a major olive oil polyphenol, is not 
transferred across the jejunum or ileum [10].  Instead secoiridoids, such as oleuropein, reach the large 
intestine where they are degraded by the microflora to yield hydroxytyrosol and may express biological 
activity towards large intestinal cells [10].  The cellular mechanisms by which olive oil polyphenols may 
express anticancer activities in the large intestine are poorly understood, although they may act by 
modulating the activity of COX-2, as has been reported for other polyphenols [11].  COX-2 is over-expressed 
in colorectal cancer, and this over-expression has a strong association with colorectal neoplasia, by 
promoting cell survival, cell growth, migration, invasion and angiogenesis [12; 13].  In addition, the MAPK 
signalling pathway, which is known to regulate COX-2 activity [14], has long been viewed as an attractive 
pathway for anticancer therapies, due to its central role in regulating the growth and survival of cells from a 
broad spectrum of human cancers [15].  The aim of this study was to investigate the potential anti-
proliferative effects of an olive oil polyphenolic extract on human colonic cancer cells.  We show that their 
ability to inhibit cancer cell proliferation is associated with their potential to induce G2/M cell cycle block via 





Material and methods 
Materials:  The polyphenolic extract was kindly extracted by Professor Visioli and obtained by processing 
extra virgin olive oil by methanol/water extraction as previously described [16]. All the primary antibodies 
used, anti phospho-p38 MAP Kinase (Thr180/Tyr182) Ab, anti total-p38 MAP Kinase Ab, anti phospho-CREB 
(Ser133) Ab, anti total-CREB Ab and anti COX-2 Ab, were from Cell Signalling (New England Biolabs, 
Hertfordshire UK). Pre-stained molecular-mass markers were purchased from Biorad (Hemel Hempstead, 
UK). Anti-Bromodeoxyuridine Ab was from Becton Dickinson (Cowley, Oxford UK). Secondary horseradish 
peroxidase-conjugated goat anti-rabbit Ab, secondary rabbit anti-mouse FITC Ab, Ponceau Red solution, 
Sulforhodamine B based assay kit, 5-Bromo-2′-deoxyuridine (BrdU), RNAse and propidium iodide were from 
Sigma (Poole, Dorset UK). ECL reagents were from Chemicon (Millipore, Watford UK). Hyperfilm-ECL and 
nitrocellulose membrane were from Amersham Biosciences (Chalfont St.Giles UK). All other reagents used 
were obtained from Sigma. 
 
HPLC analysis: HPLC analysis was carried out with an Agilent 1100 series liquid chromatograph (Agilent 
Technologies, Palo Alto, CA) equipped with a diode array detector (DAD) linked to the HP ChemStation 
Software system as previously described [10]. Calibration curves of the commercially available compounds 
were constructed using authentic standards (0.1 to 100µM) and in each case were found to be linear with 
correlation coefficients of >0.995. 
 
Cell culture and proliferation: Caco-2 cells (ECACC Salisbury, Wiltshire UK) were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM), supplemented with 20% heat-inactivated bovine serum, 2mM L-
glutamine, 1% nonessential amino acids, 100U/ml penicillin, and 100g/ml streptomycin.  The ability of the 
olive oil polyphenol extract to inhibit cellular proliferation was tested using the sulforhodamine B (SRB) 
assay.  Cells were seeded in 24-well plates (2.5 × 104 per well) and low confluence cells (8h after seeding) 
were exposed to the olive oil polyphenolic extract (10-100g/ml) or vehicle (methanol 2%).  Cells were 
harvested following 24h, 48h, 72h and 96h in culture and fixed by the addition of 125l ice-cold TCA (10% 
final concentration; 4C; 1h). After fixing, media was removed, cells were washed and total biomass was 
determined using SRB (250l of 0.4% SRB; 0.5h).  Unincorporated dye was discarded by washing with 1% 
acetic acid, whilst cell incorporated dye was solubilised using Tris Base (10mM).  Dye incorporation, 




Cell cycle analysis: Caco-2 cells were seeded on 6 well plates (1 × 105 cells/well), grown until 80% 
confluence and treated with the polyphenol extract (10 and 50μg/ml; 24h).  The cells were analyzed to 
ascertain the cell cycle phase distribution with the two-colour flow cytometric method described by Poolman 
and Brooks [17]. Samples were analysed by flow cytometry using a FACS Calibur benchtop flow cytometer 
(Becton-Dickinson, Oxford UK) equipped with a 15mW blue argon laser source (excitation wavelength: 
488nm). The percentages of the cells in G0/G1, S and G2/M phases were assessed using the FL3-A 
channel (675nm), and the number of cells was sorted (count) at 200 for the G0/G1 population, at 400 for the 
G2/M and the S phase in between using CellFIT Cell-Cycle Analysis Version 2.0.2 software. 
 
Western Immunoblotting: Caco-2 cells (1 × 105 cells/well) were grown on 6-well plates (80% confluent) and 
were exposed to either the polyphenol extract (10-100g/ml) or to vehicle (2% methanol) for 15 min for p38 
and CREB phosphorylation or for 24h for COX-2 expression. The Bradford assay was performed to assess 
protein content and Western immunoblotting was performed as described previously [18]. Samples 
containing 20µg of protein were run on 9% SDS-acrylamide gel and proteins were transferred to 
nitrocellulose membranes by semi-dry electroblotting (1.5mA/cm2) . Blots were incubated with anti phospho-
p38 MAP Kinase (Thr180/Tyr182) Ab (1:1000 dilution), anti total-p38 MAP Kinase Ab (1:1000 dilution), anti 
phospho-CREB (Ser133) Ab (1:1000 dilution), anti total-CREB Ab (1:1000 dilution) and anti COX-2 Ab 
(1:1000 dilution) in TTBS containing 1%(w/v) skimmed milk powder. Blots were exposed to hyperfilm for 2 
minutes in an autoradiographic cassette and developed, before protein bands were quantified using Quantity 
One software.  For p38 and CREB analysis, the relative band intensity of the phosphorylated form was 
divided by the relative band intensity of the total form to obtain the ratio phospho/total. 
 
Statistical analysis:  Data are expressed as meansS.D. Statistical analysis was performed using Graph Pad 
Instat software by one-way ANOVA followed by Student’s t-test with a confidence level of 95% to identify 




Polyphenolic content of the olive oil extract:  Chromatographic separation of the olive oil polyphenolic extract 
by reverse phase HPLC-DAD (Figure 1) revealed the presence of the phenolic alcohols, hydroxytyrosol 
(6.3%, Peak 1) and tyrosol (3.0%, Peak 2), and the secoiridoid oleuropein (16.3%, Peak 3), which were 
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identified and quantified by retention time and spectra comparison with authentic phenolic standards. The 
extract also contained other secoiridoid derivatives, eluting at 40-60min RT (combined peaks identified by 4). 
 
Assessment of cytotoxicity and cell cycle:  Significant inhibition of Caco-2 cell growth was observed following 
exposure to the polyphenolic extract, as indicated by reductions in cell biomass determined by the SRB 
assay (Figure 2).  Growth inhibition was statistically significant for all concentrations tested (10-100μg/ml) at 
48h, 72h and 96h and for 50-100 μg/ml at 24h.  Untreated sub-confluent cells revealed a consistent cell 
cycle phase distribution of cells in G2/M (15.1 ± 2.5 %), G0/G1 (82.8 ± 4.2 %) and S (1.9 ± 1.7 %) phases 
(Figure 3).  Treatment with the polyphenol extract (10 μg/ml) had no significant effect on cell cycle 
distribution whilst 50μg/ml significantly blocked the cell cycle at the G2/M phase (51.82 ± 2.69), with a 
concomitant reduction in the number of cells on G0/G1 phase (40.86 ± 3.02), and did not significantly alter S 
phase (7.31 ± 5.03) (Figure 3).  
 
COX-2 expression, p38 and CREB:  COX-2 expression was dose dependently reduced following exposure of 
cells to the polyphenol extract (10-100μg/ml) for 24h (Figure 4A).  The reduction in COX-2 expression was 
significant at concentrations of 50-100 μg/ml (p<0.001), with COX-2 levels reduced by 56.9 ± 9.3 % relative 
to basal levels in response to the 50 μg/ml exposure.  The phosphorylation state of p38, which was probed 
using a phospho-specific antibody that recognizes the dually phosphorylated motif Thr180-Pro-Tyr182 within 
activated p38, was also observed to decrease in a dose-dependent manner in response to the extract (10-
100 μg/ml; 15min) (Figure 4B).  Inhibition of p38 activation was significant at concentrations of 50 μg/ml (38.7 
± 4.7 %) and higher.  Parallel immunoblots with an antibody that detects total levels (non phosphorylated and 
phosphorylated p38) indicated that there were no significant changes in total p38.  The phosphorylation state 
of CREB, which was determined by probing membranes with a phospho-specific antibody which recognises 
the phosphorylated motif Ser133, was also observed to be reduced in a dose-dependent manner in response 
to the polyphenol extract (10-100 μg/ml; 15min) (Figure 4C). The ratio of phospho/total CREB, reflecting its 




Olive oil consumption has been proposed to contribute to the lower incidence of large intestinal cancer in 
Mediterranean countries [1]. It is known to contain a variety of phenolic compounds (phenolic alcohols, 
lignans, secoiridoids), which are thought to be responsible for its reported anti-carcinogenic effects [5].  The 
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unbalanced control of cellular proliferation is a primary characteristic of cancer cells.  Therefore, compounds 
which are able to inhibit cancer cell proliferation may be useful as chemopreventive and/or chemotherapeutic 
agents.  In the present study, we demonstrate that a mixture of phenolic compounds, representative of those 
that reach the large intestine, significantly inhibit the proliferation of colonic cancer cells.  This reduction in 
cancer cell growth was mediated by the induction of a G2/M phase cell cycle block, which is in agreement 
with previous studies showing that hydroxytyrosol, a polyphenol rich in our extract, induces inhibition of the 
proliferation of human colon carcinoma cells [6; 19].  Other polyphenols, such as flavan-3-ols and their 
nitrosated derivatives have also been found to express potent anti-proliferative effects in human colon 
adenocarcinoma cells [20].  These findings are significant as whilst simple olive oil polyphenols are only 
partially absorbed in the small intestine, resulting in plasma concentrations of hydroxytyrosol, tyrosol and 
related metabolites of 1–2 µM [21; 22], the large intestinal epithelium is exposed to higher concentrations of 
a variety of polyphenols, such as hydroxytyrosol and various secoiridoid derivatives [23].   
 
The cellular mechanisms by which polyphenols exert anti-proliferative effects are poorly understood.  Our 
results indicate that olive oil polyphenols induce a cell cycle block in the G2/M phase in colonic 
adenocarcinoma cells and that this inhibition of proliferation may be mediated by an inhibition of COX-2.  
This is in agreement with previous studies which show that polyphenols present in red wine and black tea 
also inhibit colonic cancer cell growth via a mechanism involving COX-2 [11].  COX-2 expression is known to 
be regulated in a cell cycle-dependent manner and mRNA levels of COX-2 are lower when cells accumulate 
in the G2/M phase [24].  Furthermore, whilst COX-1 is constitutively expressed in the majority of tissues, 
COX-2 expression is induced by many different stimuli including mitogens and tumour promoters in a 
discrete number of cell types [25].  COX-2 is aberrantly over-expressed in many human cancers, most 
notably of colonic origin, and has been demonstrated to play a role in tumour progression and metastasis 
[12].  Multiple studies have revealed a role for COX-2 inhibitors in decreasing the risk of colon cancer 
development and in suppressing tumour formation and growth.  Thus, COX-2 is considered an important 
therapeutic target for cancer prevention [26] and its inhibition has been demonstrated for a number of other 
dietary components, such as carotenoids [27], celecoxib, [28], selenomethionine [29] and curcumin [30].  In 
agreement with our data, previous studies have indicated that tyrosol and oleocanthal (the dialdehydic form 




The regulation of COX-2 gene expression in a variety of tissues is controlled by signalling through a number 
of pathways [14], including the mitogen-activated protein kinase (MAPK) pathway [14].  MAPK kinase 
enzymes, including p38 MAPK, p42/44 MAPK, and c-Jun N-terminal kinase (JNK), have been implicated in 
the regulation of COX-2 gene expression in a variety of tissues, including the large intestine [33] and are 
involved in both transcriptional and post-transcriptional regulation of COX-2 [33].  The control of COX-2 
transcription is regulated by p38 and/or other signalling pathways through the activation of transcription 
factors, such as cyclic AMP response element binding protein (CREB), NF-κB, C/EBP, NFAT or AP-1 [14].  
We demonstrate that the olive oil polyphenols are capable of down-regulating COX-2 expression in colonic 
cancer cells by a mechanism involving the early inhibition of p38 and downstream inhibition of the 
transcription factor CREB.  These observations agree with other Caco-2 cells studies which demonstrate that 
inhibition of p38 significantly reduces COX-2 expression [34].  The induction of COX-2 via the p38/CREB 
pathway has been also demonstrated in human non-transformed colonocytes exposed to Clostridium difficile 
toxin A, which induces reactive oxygen species production and COX-2 induction.  We suggest that the anti-
proliferative effects of olive oil polyphenols, representative of those reaching the large intestine, may be 
mediated, in part, by the inhibition of p38 and CREB phosphorylation/activation leading to a reduction in 
COX-2 expression.  Such a mechanism is likely to contribute to the anticancer activity of olive oil in the large 
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Figure 1: Typical HPLC-DAD chromatogram (280 nm) obtained from the separation of the olive oil 
polyphenolic extract. 1: hydroxytyrosol (6.3%); 2: tyrosol (3%); 3: oleuropein aglycone (16.3%). Peaks at RT 
40-60min relate to secoiridoid derivatives (4). 
 
Figure 2: Growth inhibition induced by olive oil polyphenols treatment. Caco-2 cells were exposed to the 
polyphenol extract (10-100µg/ml) for 24h, 48h, 72h and 96h before Sulforhodamine B assays were 
conducted. Data are means of 3 separate experiments, each performed in quadruplicate (n=12), and 
presented as mean  SD. a = p < 0.001; c = p < 0.05 represent a significant increase in growth inhibition 
relative to vehicle treated cells. 
 
Figure 3: Effects of the olive oil polyphenolic fraction on cell cycle phase distribution. Sub-confluent Caco-2 
cells were exposed to vehicle (MeOH) or the polyphenol extract (10 and 50µg/ml) for 24h. Cells were 
trypsinized, pelleted, and collected prior to fixing/digestion with RNase. Cellular DNA was stained with PI and 
the distribution of cells in G0/G1, S and G2/M phase was analyzed by flow cytometry.  Results are obtained 
from three independent experiments and presented as means ± SD.  a = represents a significant decrease in 
cells in G0/G1 relative to vehicle treated cells, p<0.001; b = represents a significant increase in cells in G2/M 
relative to vehicle treated cells, p<0.001 
 
Figure 4: Immunoblotting analysis on Caco-2 cells exposed to polyphenolic extract. Crude lysates (20 μg) 
prepared from Caco-2 cells exposed to vehicle (MeOH) or the polyphenol extract (10-100 µg/ml) for 24h 
(COX-2) or 15min (p38 and CREB) were immunoblotted with antibodies that specifically recognize COX-2 
(panel A), phosphorylated and total p38 (panel B), and phosphorylated and total CREB (panel C). Data 
obtained from experiments were analyzed using Bio-Rad Quantity One 1-D Analysis software. Results are 
obtained from four independent experiments and presented as means ± SD.  a = p<0.001; c= p<0.05 
represent significant decrease relative to vehicle treated cells. 
 
